Skip to content

Associations between psychedelic use and adverse outcomes in substance use disorders: a real-world EHR-based cohort study.

Fares Qeadan, Ashlie McCunn, Benjamin Tingey, Paul Thielking

Front Psychiatry October 24, 2025 DOI: 10.3389/fpsyt.2025.1648104 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Population People with substance use disorders
Topics Addiction
Key findings Psychedelic use was associated with an increased risk of adverse outcomes such as emergency department visits and hospitalizations in individuals with substance use disorders.

Abstract

Associations between psychedelic use and adverse outcomes in substance use disorders: a real-world EHR-based cohort study.